Clinical trial

Repurposing Nucleoside Reverse Transcriptase Inhibitors for Treatment of AD

NCT04500847

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2021-12-17

PhasePHASE1

Study timeline

Study start (actual)2021-12-17Date precision: day

Registry last updated2025-05-04

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Alzheimer Disease, Early Onsetunresolved

Mild Cognitive Impairmentunresolved

Moderate Dementiaunresolved

Interventions

Emtriva CapsuleDRUG

Sponsors & collaborators

Butler Hospitallead sponsor

Alzheimer's Associationcollaborator

Brown Universitycollaborator

The Miriam Hospitalcollaborator

Cedars-Sinai Medical Centercollaborator

Mapped research locations

Los AngelesCalifornia, United States1 ProvidenceRhode Island, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04500847 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.